Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
- 2 December 2021
- journal article
- editorial
- Published by Elsevier BV in The Lancet
- Vol. 398 (10317), 2126-+
- https://doi.org/10.1016/S0140-6736(21)02758-6
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in QatarThe New England Journal of Medicine, 2021
- Covid-19 Vaccine Effectiveness in New York StateThe New England Journal of Medicine, 2021
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort studyThe Lancet, 2021
- The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary studyThe Lancet Microbe, 2021
- Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, ChinaEClinicalMedicine, 2021
- SARS-CoV-2 variants, spike mutations and immune escapeNature Reviews Microbiology, 2021
- New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine ImplicationsThe New England Journal of Medicine, 2021
- Published by Springer Science and Business Media LLC ,2021
- SARS-CoV-2 variants and ending the COVID-19 pandemicThe Lancet, 2021
- Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionCell Host & Microbe, 2021